Introduction
Naproxen ((+)-6 methoxy 2-naphthaleneacetic acid), a non steroidal anti-inflammatory agent, is currently widely used in rheumatic conditions. Slight and transient changes in serum transaminase levels, regressing despite continued therapy, have been reported by Frenger and Norbach (1973) and more recently jaundice was suggested as a possible side effect of naproxen (Bass, 1974; Law and Knight, 1976 (Fig. 1) . A mild degree of steatosis with small and medium sized vacuoles ( Fig. 2 ) and rare and small foci of mononuclear cell infiltration, scattered through the parenchyma were present. Portal tracts were sharply limited and moderately enlarged with oedema and infiltration by mononuclear cells and some eosinophils (Fig. 3) 
